Neil Shen
Founding Managing Partner - China @ Sequoia Capital
Neil Shen is a Series B investor at Sequoia Capital focused on Internet and E-Commerce. Neil Nanpeng Shen is one of the co-founders of our company and has been our company’s Director since our inception. Mr. Shen is the Founding Managing Partner of Sequoia Capital China. Co-founder and co-chairman at Home Inn.
- Total investments:
- 44
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Neil Shen invests in
Stages Neil Shen invests in
Countries Neil Shen invests in
Round sizes
Round size
- Series A
- $13M–$210M
- Series B
- $15M–$300M
- Series D
- $69M–$1B
Investment Focus
Industry
- Internet 4 (9%)
- E-Commerce 4 (9%)
- Biotechnology 4 (9%)
- Retail 3 (7%)
- Fashion 3 (7%)
Stage
- Series B 7 (16%)
- Series A 6 (14%)
- Series D 6 (14%)
- Series C 5 (11%)
- Series E 3 (7%)
Country
- China 8 (18%)
- United States 3 (7%)
- Hong Kong 2 (5%)
- Canada 1 (2%)
- France 1 (2%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Envision Digital is providing software solutions for organizations. | $210M / Series A / Jun 07, 2022 | |
|
|
Envision Digital is providing software solutions for organizations. | $210M / Series A / Jun 07, 2022 | |
|
|
Established in Melbourne in 2015, Airwallex is a global payments fintech that enables businesses to operate anywhere, anytime.In today’s fast-changing digital era, Airwallex's purpose is to empower businesses of all sizes to grow without borders, and by doing so, contribute to the global economy. With technology at its core, Airwallex builta proprietary global financial infrastructure platform to help businesses transact, collect and pay in any foreign currency across 130+ countries and 50+ currencies, without the constraints of the traditional global financial system. | $100M / Series E / Nov 17, 2021 | |
|
|
Established in Melbourne in 2015, Airwallex is a global payments fintech that enables businesses to operate anywhere, anytime.In today’s fast-changing digital era, Airwallex's purpose is to empower businesses of all sizes to grow without borders, and by doing so, contribute to the global economy. With technology at its core, Airwallex builta proprietary global financial infrastructure platform to help businesses transact, collect and pay in any foreign currency across 130+ countries and 50+ currencies, without the constraints of the traditional global financial system. | $100M / Series E / Nov 17, 2021 | |
|
|
Envision is a global energy internet service provider. | $1B / Private Equity / Oct 21, 2021 | |
|
|
Envision is a global energy internet service provider. | $1B / Private Equity / Oct 21, 2021 | |
|
|
Established in Melbourne in 2015, Airwallex is a global payments fintech that enables businesses to operate anywhere, anytime.In today’s fast-changing digital era, Airwallex's purpose is to empower businesses of all sizes to grow without borders, and by doing so, contribute to the global economy. With technology at its core, Airwallex builta proprietary global financial infrastructure platform to help businesses transact, collect and pay in any foreign currency across 130+ countries and 50+ currencies, without the constraints of the traditional global financial system. | $200M / Series E / Sep 20, 2021 | |
|
|
Established in Melbourne in 2015, Airwallex is a global payments fintech that enables businesses to operate anywhere, anytime.In today’s fast-changing digital era, Airwallex's purpose is to empower businesses of all sizes to grow without borders, and by doing so, contribute to the global economy. With technology at its core, Airwallex builta proprietary global financial infrastructure platform to help businesses transact, collect and pay in any foreign currency across 130+ countries and 50+ currencies, without the constraints of the traditional global financial system. | $200M / Series E / Sep 20, 2021 | |
|
|
XtalPi is a pharmaceutical technology company that is reinventing the industry’s approach to drug research and development with its Intelligent Digital Drug Discovery and Development (ID4) platform. Through its tightly interwoven quantum mechanics, artificial intelligence, and high-performance cloud computing algorithms, the ID4 platform enablespharmaceutical companies to increase their efficiency, accuracy, and success rate at critical stages of drug R&D. By accelerating the pace of drug discovery and development, XtalPi aims to contribute to a healthier society worldwide.Founded in 2014 by a group of quantum physicists at MIT, XtalPi has since grown into an elite team of researchers with multi-disciplinary expertise in physics, chemistry, pharmaceutical R&D, and algorithm design. XtalPi has received much recognition for its cutting-edge technologies, its innovative solutions, and the breadth of potential applications of its offerings across the pharmaceutical value chain, which has allowed it to gain industry approval and establish strategic partnerships with several top international pharmaceutical companies. | $400M / Series D / Aug 11, 2021 | |
|
|
XtalPi is a pharmaceutical technology company that is reinventing the industry’s approach to drug research and development with its Intelligent Digital Drug Discovery and Development (ID4) platform. Through its tightly interwoven quantum mechanics, artificial intelligence, and high-performance cloud computing algorithms, the ID4 platform enablespharmaceutical companies to increase their efficiency, accuracy, and success rate at critical stages of drug R&D. By accelerating the pace of drug discovery and development, XtalPi aims to contribute to a healthier society worldwide.Founded in 2014 by a group of quantum physicists at MIT, XtalPi has since grown into an elite team of researchers with multi-disciplinary expertise in physics, chemistry, pharmaceutical R&D, and algorithm design. XtalPi has received much recognition for its cutting-edge technologies, its innovative solutions, and the breadth of potential applications of its offerings across the pharmaceutical value chain, which has allowed it to gain industry approval and establish strategic partnerships with several top international pharmaceutical companies. | $400M / Series D / Aug 11, 2021 | |
| See all 44 investments → | |||
Co-Investors
About Sequoia Capital
Sequoia is a venture capital focused on energy, financial, enterprise, healthcare, internet, and mobile startups. The firm helps a small number of daring founders build legendary companies. It spurs them to push the boundaries of what’s possible.The firm seeks to invest in all sectors with a focus on energy, financials and financial services,healthcare and healthcare services, Internet, mobile, outsourcing, and technology.
Sequoia Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Anas Biad
Partner
|
|||
|
Andrew Lee
Vice President
|
|||
|
Carl Eschenbach
Partner
|
|||
|
Caroline Fu
Vice President
|
|||
|
Donald Valentine
Founder
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Neil Shen invest in?
Neil Shen invests primarily in Internet, E-Commerce and Biotechnology startups, most often at Series B and Series A stage. Most of the 44 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Neil Shen's check size?
Neil Shen typically joins rounds of $13M–$210M at Series A, $15M–$300M at Series B and $69M–$1B at Series D. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Neil Shen participates in.
When did Neil Shen last invest?
The most recent investment recorded for Neil Shen closed in Jun 2022. Shizune tracks 44 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!